Research Stories

News views: State of welfare (BC Centre for Excellence in HIV/AIDS)

A new study suggests that creating new or more distribution options for welfare cheques will reduce drug overdoses.

“Cheque day” linked to drug overdose risk in BC: Study (BC Centre for Excellence in HIV/AIDS)

Injection drug users are much more likely to overdose around the day government assistance cheques are issued in British Columbia, according to new research published in the International Journal of Drug Policy.

Social assistance study aims to reduce overdose rate (BC Centre for Excellence in HIV/AIDS)

A new pilot project set to launch on Vancouver's Downtown Eastside will try distributing welfare and other social assistance cheques in smaller instalments to see if it will help the recipients better manage their money, stay healthier — and even stay alive.

“Cheque day” linked to increased risk of drug overdoses: Study (BC Centre for Excellence in HIV/AIDS)

On that last Wednesday of every month, many people cash their government assistance cheques.

Study to look at ‘Welfare Wednesday’ and injection drug use (BC Centre for Excellence in HIV/AIDS)

A new study will look at whether changing the timing of when welfare cheques are issued will affect drug overdoses among recipients who use intravenous drugs.

Guest editorial: Too many drugs can cause harm (Dr. Rita McCracken)

Too much of a good thing can be a bad thing, especially when it comes to prescription drugs. Advances in pharmacology have brought huge benefits in treating and preventing disease and in extending life, but when used improperly or to excess, medications can result in more harm than good.

Newly Appointed President of The Acne and Rosacea Society of Canada Launches Natural Line for Rosacea and Sensitive Prone Skin (Dr. Jason Rivers, St. Paul's Hospital)

Riversol Skin Care Solutions Inc. has officially launched Riversol MD, a new dermatologist developed skin care line specifically created to help manage rosacea-prone skin without the use of drugs or harsh chemicals. Coinciding with the launch is the appointment of Riversol founder, Dr. Jason K. Rivers as President of the Acne and Rosacea Society of Canada, a new national, non-profit organization led by dermatologists.

iCHIP application a North American first for blood disorder patients (St. Paul’s Hospital)

Empowering patients, improving care and support, and enhancing quality of life; that’s what the newly launched iCHIP application will deliver to patients across the province of BC.

Many BC seniors prescribed multiple drugs despite risks: report

BC doctors are continuing to prescribe multiple medications to seniors even though research suggests doing so can be harmful, a newly released set of statistics show.

The Therapeutics Initiative, a group that provides independent assessments on the safety and effectiveness of pharmaceuticals in BC, came to the conclusion after reviewing data from PharmaNet.

Cindy E. Harnett reports

Click here to read the full story

New heart failure drug could reduce death by 20 per cent, trial shows

A new drug for heart failure could reduce the number of deaths from the disease by 20%, and is the first treatment in two decades to show a higher survival rate for patients, says one of BC’s top cardiologists.

Dr. Andrew Ignaszewski, head of cardiology at St. Paul’s Hospital, is one of the lead researchers into the largest heart failure study to date and was in Spain on Saturday to present the findings at the European Society of Cardiology.

He called the findings a major advancement in heart failure treatment.

Tiffany Crawford reports

Frontline staff medical studies

Frontline medical workers are receiving funding for a number of health studies, and the results are already improving the lives of patients.

Elain Yong reports

Click here to view the video

Opinion: Better addiction training on horizon

Imagine a known and immensely costly medical condition. Consider this illness has been the subject of great study, with research breakthroughs providing a clear description of its causes and treatment. Imagine that, despite this, hospitals and physicians' offices are often clogged with consequences of this condition all because of the widespread failure of the medical community to apply what has been learned to effectively diagnose and treat it.

St. Paul's takes on interns

Monday, August 11, 2014: A new medical program is giving inner city kids from Dallas the chance to learn from heart and lung researchers at St Paul’s Hospital.

Elaine Yong reports

Click here to view the video

Researchers develop screen for drug—resistant form of hepatitis C drug

A project by researchers at the University of British Columbia has developed a screening process to ensure that an effective but expensive treatment for hepatitis C (HCV) will be given to only those patients who would benefit from it.

Simeprevir is one of the most effective treatments to eliminate HCV infection. When used in combination with two other agents (interferon and ribavirin), however, almost a quarter of US HCV patients were found to have variants of the virus, with a mutation called Q80K, that responded less well to this therapy.

Genome British Columbia: Personalized Treatments Will Improve Outcomes for Hepatitis C Patients & Save Healthcare Dollars

VANCOUVER, BRITISH COLUMBIA—(Marketwired - July 29, 2014) - A group of BC scientists has implemented a sophisticated screening process to ensure an effective, but expensive, Hepatitis C virus (HCV) treatment will be given to only those patients who can derive benefit from it.

Providence’s BC Centre for Excellence in HIV/AIDS signs memorandum of understanding with the Queensland Government

Queensland and the BC Centre for Excellence in HIV/AIDS are joining forces to conquer HIV/AIDS.